Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemically dependent physicians and informed consent disclosure

T F Ackerman1

  • 1Department of Human Values and Ethics, College of Medicine, University of Tennessee, Memphis 38163, USA.

Journal of Addictive Diseases
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists.

Brain research·2001
Same author

The ethics of drug research in children.

Paediatric drugs·2001
Same author

Forsaking the spirit for the letter of law: advance directives in nursing homes.

Journal of the American Geriatrics Society·1997
Same author

The moral implications of medical uncertainty: tube feeding demented patients.

Journal of the American Geriatrics Society·1996
Same author

Genetic testing of children for cancer susceptibility.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses·1996
Same author

Phase I pediatric oncology trials.

Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses·1995
Same journal

Moderate drinking or abstinence? Exploring the association of drinking status with multimorbidity in China.

Journal of addictive diseases·2026
Same journal

Sequential dual-target tDCS for tobacco use disorder: A longitudinal pilot case series targeting craving and inhibitory control.

Journal of addictive diseases·2026
Same journal

Comparative outcomes of opioid withdrawal management strategy in patients with injection-related bacteremia.

Journal of addictive diseases·2026
Same journal

Wearable physiological signals and relapse status during smoking cessation: a pilot study.

Journal of addictive diseases·2026
Same journal

Admitting powerlessness empowers recovery from substance use disorder: a conceptual model.

Journal of addictive diseases·2026
Same journal

President's message: the perilous illusion of supervised injection sites.

Journal of addictive diseases·2026
See all related articles

Physicians recovering from chemical dependency require rigorous monitoring by impaired physician programs. Mandatory patient consent disclosure is not justified if programs effectively protect patients and encourage physician referrals.

Area of Science:

  • Medical Ethics
  • Physician Health
  • Substance Use Disorders

Background:

  • Current legal and professional standards suggest physicians treated for chemical dependency should disclose their history for informed consent.
  • This is based on the perceived risk of relapse impacting patient treatment decisions.

Purpose of the Study:

  • To evaluate the necessity and justification of informed consent disclosure for physicians with a history of chemical dependency.
  • To examine the role and effectiveness of impaired physician programs in patient safety.

Main Methods:

  • Analysis of legal, ethical, and professional guidelines.
  • Assessment of the risk of relapse and patient harm.
  • Evaluation of the efficacy of impaired physician monitoring programs.
Keywords:
American Medical AssociationAmericans with Disabilities Act 1990Centers for Disease Control and PreventionLegal ApproachProfessional Patient Relationship

Related Experiment Videos

Main Results:

  • The probability of patient harm from a relapsing physician under monitoring is remote.
  • Impaired physician programs offer sensitive and specific relapse detection.
  • Mandatory disclosure may compromise physician privacy and employment rights without clear benefit.

Conclusions:

  • Rigorous monitoring by impaired physician programs is crucial for patient welfare.
  • Informed consent disclosure is not justified when effective monitoring is in place.
  • Effective impaired physician programs reduce the need for mandatory consent disclosure and enhance physician participation.